743.76 - 757.57
479.80 - 796.25
8.25M / 11.73M (Avg.)
27.40 | 27.58
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.28%
Revenue growth at 75-90% of BIDU's 4.35%. Bill Ackman would push for innovation or market expansion to catch up.
7.88%
Gross profit growth at 50-75% of BIDU's 12.52%. Martin Whitman would question if cost structure or brand is lagging.
-1.95%
Negative EBIT growth while BIDU is at 30.72%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.95%
Negative operating income growth while BIDU is at 30.72%. Joel Greenblatt would press for urgent turnaround measures.
-10.42%
Negative net income growth while BIDU stands at 584.29%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-9.85%
Negative EPS growth while BIDU is at 582.95%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-9.56%
Negative diluted EPS growth while BIDU is at 575.58%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.77%
Share reduction while BIDU is at 0.47%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.06%
Reduced diluted shares while BIDU is at 1.59%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-13.35%
Negative OCF growth while BIDU is at 311.65%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-46.44%
Negative FCF growth while BIDU is at 5255.14%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
1591.58%
10Y revenue/share CAGR above 1.5x BIDU's 446.20%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
237.11%
5Y revenue/share CAGR above 1.5x BIDU's 41.74%. David Dodd would look for consistent product or market expansions fueling outperformance.
81.46%
3Y revenue/share CAGR above 1.5x BIDU's 13.41%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
3402.34%
OCF/share CAGR of 3402.34% while BIDU is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
148.09%
5Y OCF/share CAGR above 1.5x BIDU's 2.58%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
50.52%
3Y OCF/share CAGR above 1.5x BIDU's 11.42%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
3059.73%
Net income/share CAGR above 1.5x BIDU's 31.99% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
87.41%
Positive 5Y CAGR while BIDU is negative. John Neff might view this as a strong mid-term relative advantage.
171.76%
3Y net income/share CAGR above 1.5x BIDU's 51.86%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
556.66%
10Y equity/share CAGR at 50-75% of BIDU's 990.67%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
106.25%
5Y equity/share CAGR at 75-90% of BIDU's 119.61%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
50.64%
3Y equity/share CAGR above 1.5x BIDU's 31.94%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.19%
AR growth is negative/stable vs. BIDU's 4.44%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
No Data
No Data available this quarter, please select a different quarter.
3.39%
Asset growth 1.25-1.5x BIDU's 2.53%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
2.85%
1.25-1.5x BIDU's 1.97%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
14.33%
Debt growth far above BIDU's 4.29%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
12.75%
R&D growth drastically higher vs. BIDU's 12.20%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
16.04%
SG&A growth well above BIDU's 2.75%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.